Kevin Weinfurt
@KevinWeinfurt
Followers
220
Following
1K
Media
7
Statuses
113
I do work in patient-reported outcomes research, empirical bioethics, sexual medicine, and the art of giving scientific presentations.
Duke University Medical Center
Joined August 2016
Kevin P. Weinfurt and Bryce B. Reeve discuss "Patient-Reported Outcome Measures in Clinical Research" with JAMA Statistical Editor Roger J. Lewis. Hosted on @amaedhub.
0
3
17
Join @4MelanieHawkins of @Swinburne, @RickSawatzky1 of @TrinityWestern, and @KevinWeinfurt of @DukeU for this webinar on 16 August. Registration is still open! Details at https://t.co/ftvDobl5fs.
0
4
5
Learning to use freudenfreude on social media is helpful for young users, explains recent graduate Eleanor Robb.
researchblog.duke.edu
The literature is clear: there is a dark side to engaging with social media, with linkages to depressive symptoms, a sense of social isolation, and dampened self-esteem recently revealed in the...
0
2
5
#isoqol2022 I learnt a new language & paradigm for PROM Validation in the outstanding #ISOQOL workshop: Arguing for Validity structured EB validation practice to advance PRO measurement. Many thanks @4MelanieHawkins @Nancy2Mayo @_SandraNolte @KevinWeinfurt @RichardOsborne4 & Kara
2
2
11
.@chvanhoutven writes in a @Health_Affairs essay, that although she is well-versed in how family caregivers can advocate for their patient, she had trouble navigating the system when her sister with intellectual disabilities was in the hospital. Read more https://t.co/i6jyPb7vUh
0
4
20
FDA announced public webinar for PFDD draft Guidance 3 on clinical outcome assessments. #COAs #clinicaltrials
https://t.co/ihm98tWFEW
fda.gov
On September 9, 2022, the U.S. Food and Drug Administration (FDA) is hosting a webinar for industry and other interested stakeholders.
0
3
4
ICYMI: A @DukeCancer study published in February indicates that about one in seven breast cancers detected by mammography screening are over-diagnosed. Marc D. Ryser, PhD, Assistant Professor of Population Health Sciences and Duke Mathematics, explains. @duke_pophealth
0
5
7
So excited to see this out to the public. Looking forward to all of the excellent input we’ll receive on this. #PatientReportedOutcomes #ClinicalTrials #measurement #ClinicalOutcomeAssessments
#FDA issues draft guidance on Patient-Focused Drug Development (#PFDD) to help sponsors identify or develop clinical outcome assessment measures of patients’ health that are appropriate for use in a medical product development program: https://t.co/Rwxu4BwteI
1
0
4
Miss our May newsletter? Read more about our upcoming "critical questions" workshop on #pragmatictrials, a recent paper on ethics in machine learning, and a call for research in pediatric therapeutics.
myemail.constantcontact.com
News & Updates From the NIH Pragmatic Trials Collaboratory May 2022 • Subscribe to the Newsletter • Living Textbook • Grand Rounds Hub News From the NIH Pragmatic Trials Collaboratory Join Our Virtual
0
1
3
Very well deserved!
.@lmhcurtis receives the Excellence in Professionalism Award at this year's @DukeMedSchool Spring Faculty Celebration. Well deserved! Read more: https://t.co/5GXbh4RuRo
1
2
3
Ever been concerned that the order of questions posed in a PRO affects the results? Paul Novotny et al. provide evidence that the ordering of domains does not affect the results. @SCTorg @MayoClinic @FDAOncology @EthanBasch1
https://t.co/fymZWuR8Rt
0
2
4
How frequently should PROs be required in cancer trials to avoid under-reporting of symptoms? Every week, say Bellinda King-Kallimanis and colleagues. @bellkingkal @SCTorg @FDAOncology #PFDD @ethanbasch1 #clinicaltrials
https://t.co/WMY7hfF9dm
journals.sagepub.com
Objective Although patient-reported symptoms and side effects are increasingly measured in cancer clinical trials, an appropriate assessment frequency has not y...
0
4
15
Ethan Basch, Gita Thanarajasingham and Amylou Dueck outline a list of methodological standards for the use of PROs in cancer clinical trials. @SCTorg @ethanbasch1 @bellkingkal @FDAOncology #PFDD #clinicaltrials
https://t.co/E7HOUPLDYx
0
11
28
Didn’t think I could respect and admire my friend @johnflint65 more than I already do. But this video increased that 10x. John’s courage and determination have saved countless lives and, with this video, are touching so many others. https://t.co/RicmhVXqF7
0
0
3
Join us for this year's #MWMsymposium, which will kick off with presentations to bring light to theoretical models of HRQL in pediatrics, the challenges of measuring QOL and solutions to these challenges. Learn more: https://t.co/uJcPP1NdgW
@ChildrensPhila @DukeMedSchool
0
1
2
Click the link in our bio to register! If you have any questions, feel free to send a comment to or DM us!
0
2
3
10/ Some insightful colleagues to follow for more work on modern validity theory and health measurement: Michael Edwards @NolteGraham
@4MelanieHawkins
@RickSawatzky1 R.J. Wirth @BD_Zumbo
0
0
7
9/ Other excellent refs on modern validity theory and patient-centered outcomes https://t.co/cOmBkW20y4 https://t.co/yO3lXRNynu https://t.co/JzfzKq23N8 https://t.co/2B5NUBFRKd https://t.co/Ey1PZBsJyI
1
0
8
8/ Recently published example applying this approach to a complex performance outcome measure (PerfO). https://t.co/uChSTZ7u2I
#PatientReportedOutcomes
#PerformanceOutcome
#ClinicalOutcomes
#validity
journals.sagepub.com
Background Clinical trials that evaluate new medical products often use clinical outcome assessments to measure how patients feel or function. Determining the e...
1
1
6
7/ Simple summary: What would you like to say or do with scores from the measure? What’s the rationale? What supporting evidence do you have/need for the rationale? If rationale is reasonably supported by the evidence, your intended interpretation/use of scores is justified.
1
0
7